melatonin has been researched along with rotenone in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.35) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (26.09) | 29.6817 |
2010's | 14 (60.87) | 24.3611 |
2020's | 2 (8.70) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Hoebeke, J; Nijen, GV | 1 |
Kalendo, GS; Karu, TI; Pyatibrat, LV | 1 |
Boulamery, A; Bruguerolle, B; Papa, K; Simon, N; Vidal, J | 1 |
Birman, S; Coulom, H | 1 |
Mohanakumar, KP; Saravanan, KS; Sindhu, KM | 1 |
Ching, CH; Chuang, JI; Huang, JY; Lin, CH | 1 |
Cannon, JR; Greenamyre, JT; Tapias, V | 1 |
Chen, J; Chen, L; Lu, X; Pei, Z; Shen, C; Zeng, J; Zhou, H | 1 |
Goswami, P; Gupta, S; Kamat, PK; Nath, C; Patro, IK; Singh, S; Swarnkar, S | 1 |
Andreatini, R; Barbiero, JK; Bassani, TB; Boschen, SL; da Cunha, C; Gradowski, RW; Lima, MM; Santiago, RM; Vital, MA; Zaminelli, T | 1 |
Jagota, A; Mattam, U | 2 |
Goswami, P; Gupta, S; Joshi, N; Sharma, S; Singh, S | 1 |
Carriere, CH; Kang, NH; Niles, LP | 1 |
Cheang, T; Chen, L; Chen, S; Feng, J; Pei, Z; Su, F; Zheng, Y; Zhou, H | 1 |
Andrabi, SS; Parveen, S; Parvez, S; Rasheed, MZ; Salman, M; Shaquiquzzaman, M; Tabassum, H | 1 |
Cui, XS; Nie, ZW; Niu, YJ; Shin, KT; Zhou, W | 1 |
Choudhury, SR; Karmakar, S; Srivastava, AK | 1 |
23 other study(ies) available for melatonin and rotenone
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Quantitative turbidimetric assay for potency evaluation of colchicine-like drugs.
Topics: Animals; Carbamates; Colchicine; Dose-Response Relationship, Drug; Glycoproteins; Griseofulvin; Melatonin; Microtubules; Nephelometry and Turbidimetry; Podophyllotoxin; Rats; Rotenone; Tubulin; Vinblastine; Vincristine | 1975 |
Cell attachment modulation by radiation from a pulsed light diode (lambda = 820 nm) and various chemicals.
Topics: Ascorbic Acid; Cell Adhesion; Cells, Cultured; Dinitrophenols; Dose-Response Relationship, Radiation; Ethanol; HeLa Cells; Humans; Hydrogen Peroxide; Inorganic Chemicals; Laser Therapy; Mannitol; Melatonin; Methylene Blue; Organic Chemicals; Probability; Reference Values; Rotenone; Sensitivity and Specificity; Superoxide Dismutase | 2001 |
Circadian rhythms of oxidative phosphorylation: effects of rotenone and melatonin on isolated rat brain mitochondria.
Topics: Animals; Antioxidants; Brain; Circadian Rhythm; Male; Melatonin; Mitochondria; Oxidative Phosphorylation; Rats; Rats, Wistar; Rotenone; Time Factors; Uncoupling Agents | 2003 |
Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster.
Topics: Animals; Antioxidants; Apoptosis; Brain; Cell Count; Dopamine; Dopamine Agonists; Drosophila melanogaster; Electron Transport Complex I; Insecticides; Levodopa; Locomotion; Melatonin; Nerve Degeneration; Neurons; Oxidative Stress; Parkinsonian Disorders; Phenotype; Rotenone | 2004 |
Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model.
Topics: Animals; Catalase; Glutathione; Hydroxyl Radical; Male; Melatonin; Oxidative Stress; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotenone; Submitochondrial Particles; Substantia Nigra; Superoxide Dismutase | 2007 |
Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats.
Topics: Animals; Cell Count; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Down-Regulation; Melatonin; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Dopamine D2; Rotenone; Up-Regulation | 2008 |
Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.
Topics: Animals; Body Weight; Cell Count; Cell Death; Corpus Striatum; Disease Models, Animal; Dopamine; Melatonin; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Random Allocation; Rats; Rats, Inbred Lew; Rotenone; Substantia Nigra; Survival Analysis; Tyrosine 3-Monooxygenase | 2010 |
Melatonin protects against rotenone-induced cell injury via inhibition of Omi and Bax-mediated autophagy in Hela cells.
Topics: Autophagy; bcl-2-Associated X Protein; Cell Survival; HeLa Cells; High-Temperature Requirement A Serine Peptidase 2; Humans; Melatonin; Mitochondrial Proteins; Protective Agents; RNA, Small Interfering; Rotenone; Serine Endopeptidases | 2012 |
Rotenone-induced apoptosis and role of calcium: a study on Neuro-2a cells.
Topics: Animals; Antioxidants; Apoptosis; Astrocytes; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Caspase 3; Cell Line, Tumor; Cell Nucleus Shape; DNA Damage; Gene Expression Regulation, Enzymologic; Melatonin; Mice; Nerve Tissue Proteins; Osmolar Concentration; Pesticides; Reactive Nitrogen Species; Reactive Oxygen Species; RNA, Messenger; Rotenone | 2012 |
Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats.
Topics: Animals; Antidepressive Agents; Corpus Striatum; Dopamine; Male; Melatonin; Motor Activity; Neuroprotective Agents; Norepinephrine; Parkinsonian Disorders; Pars Compacta; Random Allocation; Rats, Wistar; Rotenone; Serotonin; Tyrosine 3-Monooxygenase | 2014 |
Daily rhythms of serotonin metabolism and the expression of clock genes in suprachiasmatic nucleus of rotenone-induced Parkinson's disease male Wistar rat model and effect of melatonin administration.
Topics: Animals; ARNTL Transcription Factors; Circadian Rhythm; CLOCK Proteins; Cryptochromes; Disease Models, Animal; Gene Expression; Male; Melatonin; Parkinson Disease, Secondary; Period Circadian Proteins; Rats; Rats, Wistar; Rotenone; Serotonin; Suprachiasmatic Nucleus; Time Factors | 2015 |
Astrocyte activation and neurotoxicity: A study in different rat brain regions and in rat C6 astroglial cells.
Topics: Animals; Astrocytes; Brain; Cells, Cultured; Glutathione; Melatonin; Membrane Potential, Mitochondrial; Mice; Nitrites; Rats; Rats, Sprague-Dawley; Rotenone | 2015 |
Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's disease.
Topics: Animals; Antioxidants; Corpus Striatum; Disease Models, Animal; Immunohistochemistry; Male; Melatonin; Parkinsonian Disorders; Random Allocation; Rats; Rats, Sprague-Dawley; Rotenone; Substantia Nigra; Uncoupling Agents | 2016 |
Daily chronomics of proteomic profile in aging and rotenone-induced Parkinson's disease model in male Wistar rat and its modulation by melatonin.
Topics: Age Factors; Aging; Animals; Biomarkers; Brain; Circadian Rhythm; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Male; Melatonin; Nerve Tissue Proteins; Parkinsonian Disorders; Pineal Gland; Proteomics; Rats, Wistar; Rotenone; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Substantia Nigra; Suprachiasmatic Nucleus; Time Factors | 2017 |
Melatonin inhibits rotenone-induced SH-SY5Y cell death via the downregulation of Dynamin-Related Protein 1 expression.
Topics: Cell Death; Cell Line, Tumor; Cytochromes c; Cytoprotection; Dose-Response Relationship, Drug; Down-Regulation; Dynamins; GTP Phosphohydrolases; Humans; Melatonin; Microtubule-Associated Proteins; Mitochondria; Mitochondrial Proteins; Neurons; Protein Transport; Rotenone | 2018 |
Melatonin Improves Behavioral and Biochemical Outcomes in a Rotenone-Induced Rat Model of Parkinson's Disease.
Topics: Animals; Disease Models, Animal; Male; Melatonin; Muscle Strength; Neurotoxins; Neurotransmitter Agents; Parkinson Disease; Postural Balance; Psychomotor Disorders; Rats; Rats, Wistar; Rotenone; Tyrosine 3-Monooxygenase | 2018 |
Melatonin enhances mitochondrial biogenesis and protects against rotenone-induced mitochondrial deficiency in early porcine embryos.
Topics: Animals; Embryo, Mammalian; Embryonic Development; Melatonin; Mitochondria; Mitochondrial Diseases; Rotenone; Swine | 2020 |
Neuronal Bmi-1 is critical for melatonin induced ubiquitination and proteasomal degradation of α-synuclein in experimental Parkinson's disease models.
Topics: alpha-Synuclein; Animals; Brain; Cell Line, Tumor; Female; Humans; Melatonin; Mice; Mice, Inbred BALB C; Models, Animal; Neuroprotection; Parkinson Disease; Phosphorylation; Polycomb Repressive Complex 1; Polycomb-Group Proteins; Proteasome Endopeptidase Complex; Rats; Rotenone; Ubiquitination | 2021 |